Apolipoprotein E4 (apoE4) is the strongest genetic risk factor for Alzheimer’s disease (AD). However, the exact mechanisms by which apoE4 contributes to AD pathology remain incompletely understood. Single-domain antibodies (nanobodies) are powerful tools to gain new mechanistic insights into protein function. In this project, apoE targeting nanobodies were developed as a toolbox to study apoE4.